Page 29 of 39 · 913 questions tagged clinical-trials.
Stated plainly: dulaglutide · FLOW. The empirical answer seems settled. The explanation does not. If the honest answer is that nobody knows, I would rather hear that…
The particulars: SURMOUNT-5 · nausea · 30 mg. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern is that I…
The specifics, since they change the answer: SELECT · headache. I want to understand what this actually establishes, as opposed to what it is being used to imply. My…
I have three data points across nine months, which I hope is enough to see a trend. This should be a straightforward calculation and I keep getting two different…
Concretely: ESSENCE · liraglutide. I want to know whether there is evidence behind this or only repetition. I have checked the obvious registries and monographs…
I am reading the trial table rather than the press release, which is why the numbers differ. I want to understand what this actually establishes, as opposed to what…
Numbers first: TRIUMPH-3 · dulaglutide. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to…
My records go back to the first dose with dates, so I can reconstruct the timeline exactly. I have read the primary source rather than the summary, which has left me…
For reference: STEP 8 · survodutide. Somebody stated this to me confidently and I would like to check it before repeating it. I would accept a well-reasoned negative…
For reference: tirzepatide · semaglutide. The comparison I want does not seem to exist anywhere in a form I can evaluate. I have read the arguments for each and they…
What I have: twelve weeks · retatrutide. I would rather be corrected now than propagate something wrong. I am specifically not interested in a testimonial; I am…
I am reading the trial table rather than the press release, which is why the numbers differ. I can do the algebra. I am not confident about the conversion factors. If…
What I am working with: constipation · a GLP-1 receptor agonist · SURPASS-3. I have read the primary source rather than the summary, which has left me with more…
This is a first order from this supplier, so I have no track record to reason from. The empirical answer seems settled. The explanation does not. If the honest answer…
Setup, so nobody has to ask: TRIUMPH-3 · a GLP-1 receptor agonist. I would like help reading this properly rather than being told what conclusion to reach. I have the…
The case in front of me: SELECT · tirzepatide. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the…
The case in front of me: ecnoglutide · liraglutide. These are treated as interchangeable and I do not think they are. If both are acceptable I would like to know…
Concretely: survodutide · retatrutide. I would like the axes of comparison first and the recommendation second. I have tried the first option and it works; the…
The case in front of me: ecnoglutide · minus 20 °C. I want to know whether there is evidence behind this or only repetition. I have checked the obvious registries and…
What I have: REDEFINE-1 · 40 mg. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone else’s…
Concretely: constipation · tirzepatide · SUSTAIN-6. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a…
What I have: a GLP-1 receptor agonist · 4 °C. I am asking for verification rather than opinion, ideally with something I can read myself. It is possible the evidence…
Stated plainly: early satiety · mazdutide · STEP 5. I would like help reading this properly rather than being told what conclusion to reach. I have the full report…
Concretely: SUSTAIN-6 · liraglutide. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the specifics…